ECTE

Echo Therapeutics (PK) Stock Price

0.021
0.00 (0.0%)
0.021

Low
0.004

52 Week Range

High
0.28

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Echo Therapeutics (PK) ECTE OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.021 16:00:24
Open Price Low Price High Price Close Price Prev Close
0.021 0.021 0.021 0.021 0.021
Bid Price Ask Price Spread News
0.017 0.0385 0.0215 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1 1,890 $ 0.021 $ 40 - 0.004 - 0.28
Last Trade Time Type Quantity Stock Price Currency
09:30:06 1,890 $ 0.021 USD

Echo Therapeutics (PK) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 279.24k 13.30M 10.88M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.52k $ - 0.00% - -

more financials information »

Echo Therapeutics (PK) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ECTE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.03230.03850.0210.022521721,273-0.0113-34.98%
1 Month0.042150.04690.0210.028560527,519-0.02115-50.18%
3 Months0.02950.280.0120.036639780,214-0.0085-28.81%
6 Months0.0099350.280.0040.030718857,2770.01107111.37%
1 Year0.01150.280.0040.027952536,7280.009582.61%
3 Years0.00710.280.00050.015056132,6900.0139195.77%
5 Years1.451.450.00050.086074532,401-1.43-98.55%

Echo Therapeutics (PK) Description

We are a medical device company with expertise in advanced skin permeation technology. We are developing a non-invasive. wireless continuous glucose monitoring (CGM) system for initial use in the diabetes outpatient market. We believe other significant opportunities exist in the wearable-health consumer market and the hospital setting. The transdermal skin preparation component of our CGM System allows for enhanced skin permeation that will enable extraction of analytes such as glucose, enhanced delivery of topical pharmaceuticals and other applications.


Your Recent History
USOTC
ECTE
Echo Thera..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.